DERM
Journey Medical Stock Analysis
AI Rating
- Quality0/10
- Growth↓ 2/10
- Value↓ 1/10
DERM Growth
- Revenue Y/Y↑ 10.20%
- EPS Y/Y↑ 34.72%
- FCF Y/Y↓ -36.31%
DERM Profitability
- Gross margin ↑ 66.20%
- EPS margin↓ -18.50%
- ROIC 5Y↓ -33.73%
DERM Risk
- Debt / Equity↓ 0.8
- Debt / FCF↓ 0.1
- Interest coverage↓ -2.1
Journey Medical stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.